In this episode, host Shikha Jain, MD, speaks with Maureen McBeth, PT, MPT, CLT-LANA, about understanding individualized patient experiences with lymphedema, the value of exercise oncology and more.

•    Welcome to another exciting episode of Oncology Overdrive 0:14
•    About McBeth 0:23
•    The interview 0:52
•    How did you end up in the lymphedema and cancer rehab space? 1:31
•    Why is lymphedema such a big topic, especially in the breast cancer space? 3:20
•    Jain and McBeth on the complexities of individual lymphedema cases, including studies on lymphatic imaging. 5:25
•    Do you feel like there have been advancements in the lymphedema space that can improve our understanding of it?  9:43
•    Have stigmas around lymphedema evolved over the years? 12:31
•    McBeth on the educational materials available to physicians surrounding cancer-related lymphedema and prospective surveillance. 15:15
•    Tell us about ImpediMed and its purpose. 17:06
•    How do you incorporate these technologies into the current dialogue about more holistic care? 21:27
•    Jain and McBeth on exercise oncology and its impact on overall survival. 24:22
•    In ten years, what would you envision as the future of lymphedema and exercise oncology? 29:01
•    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 32:31
•    How to contact McBeth 33:33
•    Thanks for listening 34:20

Maureen McBeth, PT, MPT, CLT-LANA, is a licensed physical therapist and certified lymphedema therapist with over 25 years of experience in oncology rehabilitation, clinical education, and patient advocacy. She currently serves as senior medical affairs liaison at ImpediMed.

We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. McBeth can be reached via email mmcbeth@impedimed.com. Learn more about ImpediMed at https://www.impedimed.com/, or follow them on LinkedIn or Instagram @impedimedhealth.

References
•    Pasket ED, et al. J Clin Oncol. 2012;doi:10.1200/JCO.2012.41.8574
•    Schmitz KH, et al. J Natl Cancer Inst Monogr. 2025;doi:10.1093/jncimonographs/lgaf007.
•    Stout NL, et al. Cancer. 2012;doi:10.1002/cncr.27476.

Disclosures: Jain and McBeth report no relevant financial disclosures.